Forward Citations = 38

Loading Chart...

9 inventors (with patents filed for the assignee):

Geert Jan Sterk (4 out of 28 patents)

Hendrik Timmerman (4 out of 11 patents)

Jan Bron (3 out of 6 patents)

4. Jan F Van Der Werf (3 out of 4 patents)

5. Henk Timmerman (1 out of 1 patent)

6. Henk Van Der Goot (1 out of 1 patent)

7. John C Eriks (1 out of 1 patent)

8. Henderikus Van Der Goot (1 out of 2 patents)

9. Jan G Koper (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 5385922 - Thiazolidine derivatives (1995-01-31),

2. 5378718 - 1,4-dihydropyridine derivatives (1995-01-03),

3. 5190589 - Compounds and process preparing a substituted or an unsubstituted (1993-03-02),

4. 5049694 - Pharmaceutical composition having relaxing activity which contains a (1991-09-17),

5. 5010095 - N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine (1991-04-23),

Company Overview

Cedona Pharmaceuticals B.v. is a leading pharmaceutical company specializing in the development, manufacturing, and distribution of high-quality generic and specialty pharmaceutical products. With a strong focus on innovation and customer satisfaction, Cedona Pharmaceuticals B.v. strives to improve patient outcomes through the delivery of safe and effective medications. With a diverse portfolio of products, Cedona Pharmaceuticals B.v. is dedicated to providing affordable healthcare solutions for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#7 in Haarlem

#1,131 in Netherlands

Haarlem, Netherlands

Cedona Pharmaceuticals B.v.

Forward Citations = 38

9 inventors:

Geert Jan Sterk (4 out of 28 patents)

Hendrik Timmerman (4 out of 11 patents)

Jan Bron (3 out of 6 patents)

4. Jan F Van Der Werf (3 out of 4 patents)

5. Henk Timmerman (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cedona Pharmaceuticals B.v.. Retrieved from https://idiyas.com/company/cedona-pharmaceuticals-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]